ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,318, issued on March 25, was assigned to ReCode Therapeutics Inc. (Menlo Park, Calif.).
"Polynucleotide compositions, related formulations, and methods of use thereof" was invented by Mirko Hennig (Mountain View, Calif.), Daniella Ishimaru (Menlo Park, Calif.), David J. Lockhart (Menlo Park, Calif.), Michael Torres (Menlo Park, Calif.), Jackson Eby (Menlo Park, Calif.), Dmitri Boudko (Menlo Park, Calif.) and Brandon A. Wustman (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions of polynucleotide(s), pharmaceutical compositions thereof, and methods of use thereof are disclosed. A polynucleotide may encode for a cystic fibrosis tra...